Ftse Mib
33.773,78
0,08%
DAX
17.932,60
0,06%
S&P 500
5.018,39
-0,34%
NASDAQ Composite
15.605,48
-0,33%
Bitcoin
57.663,18
-0,99%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Cellectar Biosciences Inc (CLRB) Cellectar Biosciences Inc (CLRB) Notizie

Cellectar Biosciences Inc

CLRB
3,20
0,04 (1,27%)
Pre Mercato
Ultimo aggiornamento: 11:54:28
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
27/3/202411:40GLOBECellectar Biosciences Reports Financial Results for Year..
20/3/202411:40GLOBECellectar Biosciences to Announce 2023 Year End Earnings..
14/3/202413:52GLOBECellectar Biosciences to Present at the 36th Annual Roth..
04/3/202412:40GLOBECellectar Biosciences Reports High Rate of Complete..
15/2/202402:31EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202422:29EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202412:40GLOBECellectar Biosciences to Present at the Oppenheimer 34th..
02/2/202412:03EDGAR2Form 8-K - Current report
31/1/202414:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
30/1/202412:40GLOBECellectar Biosciences Announces Enrollment of the First..
25/1/202422:30EDGAR2Form 8-K - Current report
25/1/202412:40GLOBECellectar Biosciences Announces Tranche A Warrants Fully..
22/1/202412:40GLOBECellectar Biosciences Reports Complete Central Nervous..
16/1/202412:40GLOBECellectar Biosciences Broadens Pipeline with Targeted Alpha..
12/1/202412:44GLOBECellectar Biosciences to Host Conference Call with Texas..
11/1/202412:40GLOBECellectar Biosciences Partners with MiBA, a Data Subsidiary..
09/1/202412:02EDGAR2Form 8-K - Current report
08/1/202412:30GLOBECellectar Biosciences Announces Positive Topline Data..
03/1/202414:30GLOBECellectar Biosciences to Announce Top-line Data from WM..
19/12/202314:30GLOBECellectar Biosciences Expands Iopofosine I 131 Collaboration..
13/12/202302:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202302:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202302:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202302:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202314:30GLOBECellectar Biosciences Strengthens Intellectual Property..
05/12/202314:30GLOBECellectar Biosciences to Present at the Targeted..
29/11/202322:31EDGAR2Form 8-K - Current report
13/11/202312:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202312:45EDGAR2Form 8-K - Current report
31/10/202305:15EDGAR2Form EFFECT - Notice of Effectiveness
27/10/202322:40EDGAR2Form 8-K - Current report
25/10/202322:54EDGAR2Form S-3/A - Registration statement under Securities Act of..
05/10/202322:45EDGAR2Form S-3 - Registration statement under Securities Act of..
02/10/202322:40EDGAR2Form DEF 14A - Other definitive proxy statements
22/9/202322:40EDGAR2Form PRE 14A - Other preliminary proxy statements
08/9/202323:17EDGAR2Form 8-K - Current report
21/8/202322:30EDGAR2Form 8-K - Current report
14/8/202314:45EDGAR2Form 8-K - Current report
14/8/202314:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
29/6/202322:31EDGAR2Form 8-K - Current report
29/6/202312:03EDGAR2Form 8-K - Current report
29/6/202300:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/6/202300:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/6/202300:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: Min: Max:
Chiusura: 3,16

La tua Cronologia

NASDAQ
CLRB
Cellectar Biosciences
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network